Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · IEX Real-Time Price · USD
9.45
-0.05 (-0.53%)
Jul 19, 2024, 12:00 AM EDT - Market open
Avid Bioservices Employees
Avid Bioservices had 371 employees as of April 30, 2024. The number of employees increased by 6 or 1.64% compared to the previous year.
Employees
371
Change (1Y)
6
Growth (1Y)
1.64%
Revenue / Employee
$377,119
Profits / Employee
-$379,388
Market Cap
600.84M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ZimVie | 2,600 |
Emergent BioSolutions | 1,600 |
Adaptive Biotechnologies | 709 |
Pharming Group | 382 |
Surmodics | 376 |
Allogene Therapeutics | 233 |
ProKidney | 163 |
Annexon | 71 |
CDMO News
- 19 days ago - Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 - GlobeNewsWire
- 21 days ago - Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 - GlobeNewsWire
- 2 months ago - Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance - GlobeNewsWire
- 2 months ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO - PRNewsWire
- 2 months ago - Avid Bioservices to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 - GlobeNewsWire
- 4 months ago - Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q - GlobeNewsWire
- 4 months ago - Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors - Business Wire